PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF

Title:

PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2024/032584

Kind Code:

A1

Abstract:

The present invention relates to a protein tyrosine kinase inhibitor for treating protein tyrosine kinase-mediated proliferative diseases or symptoms, such as ocular diseases and malignant tumors accompanied by pathological neoangiogenesis, retinal ischemia, retinal edema and diabetic retinopathy. Specifically, the present invention relates to a compound with inhibitory activity against protein tyrosine kinases and/or improved solubility and ocular bioavailability, and use thereof in treating ocular diseases and malignant tumors.

More Like This:

JP2019001819	PYRROLIDINYL UREA AND PYRROLIDINYL THIOUREA COMPOUNDS AS TRKA KINASE INHIBITORS
JP5746334	GPR120 receptor agonist and its use
WO/2020/249096	FUSED RING COMPOUND AS FGFR AND VEGFR DUAL INHIBITOR

Inventors:

HU QIYUE (CN)
XI ZHIGUO (CN)
LIU SUXING (CN)

Application Number:

PCT/CN2023/111668

Publication Date:

February 15, 2024

Filing Date:

August 08, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BEYOND THERAPEUTICS CO LTD (CN)

International Classes:

A61K31/416; C07D231/56; A61P7/00; A61P27/02; A61P27/06; C07D401/04; C07D401/12; C07D401/14; C07D403/12; C07D403/14; C07D405/12; C07D405/14; C07D413/12; C07D413/14; C07D417/12; C07D417/14; C07D419/12; C07D419/14

Domestic Patent References:

WO2001002369A2	2001-01-11
WO2022143628A1	2022-07-07

Foreign References:

CN1374950A	2002-10-16
CN1495171A	2004-05-12
US20040192735A1	2004-09-30

Attorney, Agent or Firm:

BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: BUSBAR DEVICE

Next Patent: DATA PROCESSING METHOD AND APPARATUS, NEURAL NETWORK MODEL, DEVICE, AND MEDIUM